Inventor · disambiguated record
Shun Shimizu
Also filed as: SHIMIZU SHUN
10 granted patents·11 pending applications·53 citations·filing 2011–2025
87Inventor score
Top patents by PatentIndex Score
21 records- 0194US11912989B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·3 cites·14 claims
- 0293US11673947B2Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 13, 2023·7 cites·51 claims
- 0392US10024867B2Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Jul 17, 2018·24 cites·18 claims
- 0491US11891434B2Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Feb 6, 2024·6 cites·32 claims
- 0589US10961530B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 30, 2021·6 cites·21 claims
- 0688US11952422B2Antigen-binding molecule comprising altered antibody variable region binding CD3 and CD137CHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 9, 2024·4 cites·15 claims
- 0783US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 0878US2023279099A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0978US2024158482A1Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1078US2024158785A1Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1177US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 1272US2022187308A1Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1371US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 1467US2024270846A1Antigen-binding molecule comprising altered antibody variable region binding cd3 and cd137CHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1563US11243210B2Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Feb 8, 2022·0 cites·11 claims
- 1662US2023058982A1Anti-ctla-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1762US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1855US2014234340A1Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyIGAWA TOMOYUKI·Filed 2011·Application pending·0 cites
- 1955US2023322898A1Pharmaceutical composition comprising cell expressing chimeric receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2053US2015166654A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 2139US2021292409A1Target cell specific cytosol-penetrating antigen-binding moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shun Shimizu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →